Security key
747324101
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)
CUSIP: 747324101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 62,130,557
- Total 13F shares
- 27,885,908
- Share change
- -355,890
- Total reported value
- $103,378,553
- Put/Call ratio
- 10%
- Price per share
- $3.67
- Number of holders
- 91
- Value change
- -$998,440
- Number of buys
- 50
- Number of sells
- 26
Report period
Q3 2024
Institutions
91
Top holders
10
PYXS full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Pyxis Oncology, Inc. SEC filings
Pyxis Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 747324101
Recent filing periods:
Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PFIZER INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
7,032,770
|
$19,410,445 | — | 17 Mar 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
6.7%
|
4,184,100
|
$13,849,371 | — | 30 Jun 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
6.2%
|
3,861,179
|
$12,780,502 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.5%
|
2,785,895
|
$9,221,313 | — | 30 Jun 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
4.1%
|
2,562,942
|
$8,483,338 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
2,060,444
|
$6,820,070 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
2.7%
|
1,662,408
|
$5,502,571 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
3/4/5
13F
|
10%+ Owner · Company |
0.03%
from 13F
|
3,477,975
|
$4,869,165 | — | 26 Apr 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.2%
|
1,336,908
|
$4,425,165 | — | 30 Jun 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
1.9%
|
1,202,675
|
$3,980,854 | — | 30 Jun 2024 | |
| Bayer World Investments B.V. |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
2,742,338
|
$3,839,273 | — | 13 Oct 2021 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
1.7%
|
1,046,025
|
$3,462,343 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,027,711
|
$3,401,994 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
742,907
|
$2,459,022 | — | 30 Jun 2024 | |
| Aberdeen Group plc |
13F
|
Company |
1.1%
|
708,303
|
$2,344,483 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.79%
|
492,462
|
$1,630,049 | — | 30 Jun 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.78%
|
484,443
|
$1,603,506 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
1,118,854
|
$1,566,396 | — | 13 Oct 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.62%
|
382,606
|
$1,266,426 | — | 30 Jun 2024 | |
| Jay Feingold |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
747,862
mixed-class rows
|
$1,089,573 | — | 24 Mar 2023 | |
| Decheng Capital LLC |
13F
|
Company |
0.53%
|
326,810
|
$1,081,741 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.5%
|
311,630
|
$1,031,495 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.4%
|
246,495
|
$815,898 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.38%
|
238,390
|
$789,071 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.24%
|
149,024
|
$493,270 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
129,761
|
$429,509 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.21%
|
128,396
|
$424,991 | — | 30 Jun 2024 | |
| Ken Kobayashi |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
110,878
|
$424,663 | — | 29 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.19%
|
117,248
|
$388,091 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.19%
|
115,695
|
$382,950 | — | 30 Jun 2024 | |
| Alpine Global Management, LLC |
13F
|
Company |
0.19%
|
115,514
|
$382,351 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.18%
|
114,387
|
$379,000 | — | 30 Jun 2024 | |
| PIER 88 INVESTMENT PARTNERS LLC |
13F
|
Company |
0.18%
|
113,700
|
$376,347 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.16%
|
96,936
|
$320,858 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.15%
|
95,703
|
$316,777 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
82,611
|
$273,443 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.13%
|
81,934
|
$271,202 | — | 30 Jun 2024 | |
| Ronald Herbst |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
118,674
mixed-class rows
|
$234,796 | — | 07 Oct 2021 | |
| Fan Yu |
13F
|
Individual |
0.11%
|
69,303
|
$229,393 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.11%
|
68,012
|
$225,120 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.11%
|
65,287
|
$216,093 | — | 30 Jun 2024 | |
| Cable Car Capital, LP |
13F
|
Company |
0.1%
|
61,606
|
$203,916 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.09%
|
58,252
|
$192,814 | — | 30 Jun 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.09%
|
57,025
|
$188,753 | — | 30 Jun 2024 | |
| Man Group plc |
13F
|
Company |
0.09%
|
52,954
|
$175,278 | — | 30 Jun 2024 | |
| UNIVERSITY OF CHICAGO |
13F
|
Company |
0.08%
|
48,731
|
$161,300 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
44,782
|
$148,228 | — | 30 Jun 2024 | |
| SCHULHOFF & CO INC |
13F
|
Company |
0.07%
|
42,000
|
$139,020 | — | 30 Jun 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.07%
|
40,756
|
$134,000 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.06%
|
36,290
|
$120,120 | — | 30 Jun 2024 |
Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q3 2024
As of 30 Sep 2024,
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,885,908 shares.
The largest 10 holders included
Deep Track Capital, LP, Laurion Capital Management LP, BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Blue Owl Capital Holdings LP, GEODE CAPITAL MANAGEMENT, LLC, Ikarian Capital, LLC, STATE STREET CORP, and abrdn plc.
This page lists
91
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
78
Q3 2024 holders
91
Holder diff
13
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.